首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection. 局部复发直肠或乙状结肠癌切除术患者的十年生存率和复发模式。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-05 DOI: 10.1111/codi.17226
J N Wiig, Vegar Johansen Dagenborg, Stein Gunnar Larsen

Aim: The aim of this work is to report actual overall survival (AOS) at 5 and 10 years after multimodal treatment for locally recurrent rectal or sigmoid cancer (LRRC) and the importance of local re-recurrence (reLRRC) and distant metastases for AOS.

Method: All patients resected for LRRC at a single centre between years 1990 and 2007 were included. Resections were based on images taken after neoadjuvant treatment. Patients were prospectively followed up for 5 years. After a minimum of 10 years, the records of referring hospitals were analysed.

Results: A total of 224 patients underwent resection. At 5 and 10 years 33% and 17%, respectively, had survived. Median survival was 38 months [interquartile range (IQR) 62 months]. Patients with complete resections had 5- and 10-year survival of 56% and 28%, respectively, versus 22% and 11% for those with microscopic remaining tumour; none with macroscopic remains survived beyond 4 years. Median survival was 71 months (IQR 106 months), 33 months (IQR 35 months) and 15 months (IQR 17 months), respectively. With a median survival of 123 months (IQR 80 months), the 54 patients without recurrence had 5- and 10-year survival of 69% and 59%, respectively. The independent predictor of survival was R-stage. Of the 197 patients who had radical resection, 83 developed reLRRC and 108 distant metastases. ReLRRC appeared at a median of 18 months (IQR 21 months) and distant metastases at 12 months (IQR 21 months). Lung metastases were the most common form of distant disease.

Conclusion: More than 5 years postoperatively the mortality from cancer was substantial. Most metastases appeared not to be secondary to reLRRC. Planning surgery from pretreatment images might reduce reLRRC.

目的:本研究的目的是报告局部复发性直肠或乙状结肠癌(LRRC)多模式治疗后5年和10年的实际总生存率(AOS),以及局部复发(reLRRC)和远处转移对AOS的重要性。方法:纳入1990年至2007年间在同一中心接受LRRC手术的所有患者。切除基于新辅助治疗后的图像。患者随访5年。至少10年后,对转诊医院的记录进行分析。结果:共224例患者行手术切除。5年和10年存活率分别为33%和17%。中位生存期为38个月[四分位间距62个月]。完全切除患者的5年和10年生存率分别为56%和28%,而显微镜下残留肿瘤患者的5年和10年生存率分别为22%和11%;肉眼可见的遗骸存活时间均未超过4年。中位生存期分别为71个月(IQR为106个月)、33个月(IQR为35个月)和15个月(IQR为17个月)。54例无复发患者的5年和10年生存率分别为69%和59%,中位生存期为123个月(IQR为80个月)。生存的独立预测因子为r期。在197例接受根治性切除的患者中,83例发生reLRRC, 108例发生远处转移。ReLRRC出现的中位时间为18个月(IQR 21个月),远处转移出现的中位时间为12个月(IQR 21个月)。肺转移是最常见的远处病变。结论:术后5年以上肿瘤死亡率较高。大多数转移似乎不是继发于reLRRC。根据预处理图像计划手术可能会降低reLRRC。
{"title":"Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection.","authors":"J N Wiig, Vegar Johansen Dagenborg, Stein Gunnar Larsen","doi":"10.1111/codi.17226","DOIUrl":"10.1111/codi.17226","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this work is to report actual overall survival (AOS) at 5 and 10 years after multimodal treatment for locally recurrent rectal or sigmoid cancer (LRRC) and the importance of local re-recurrence (reLRRC) and distant metastases for AOS.</p><p><strong>Method: </strong>All patients resected for LRRC at a single centre between years 1990 and 2007 were included. Resections were based on images taken after neoadjuvant treatment. Patients were prospectively followed up for 5 years. After a minimum of 10 years, the records of referring hospitals were analysed.</p><p><strong>Results: </strong>A total of 224 patients underwent resection. At 5 and 10 years 33% and 17%, respectively, had survived. Median survival was 38 months [interquartile range (IQR) 62 months]. Patients with complete resections had 5- and 10-year survival of 56% and 28%, respectively, versus 22% and 11% for those with microscopic remaining tumour; none with macroscopic remains survived beyond 4 years. Median survival was 71 months (IQR 106 months), 33 months (IQR 35 months) and 15 months (IQR 17 months), respectively. With a median survival of 123 months (IQR 80 months), the 54 patients without recurrence had 5- and 10-year survival of 69% and 59%, respectively. The independent predictor of survival was R-stage. Of the 197 patients who had radical resection, 83 developed reLRRC and 108 distant metastases. ReLRRC appeared at a median of 18 months (IQR 21 months) and distant metastases at 12 months (IQR 21 months). Lung metastases were the most common form of distant disease.</p><p><strong>Conclusion: </strong>More than 5 years postoperatively the mortality from cancer was substantial. Most metastases appeared not to be secondary to reLRRC. Planning surgery from pretreatment images might reduce reLRRC.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triple-stapling anastomosis in minimal access low anterior resection for rectal cancer: Feasible, safe and oncologically optimal-A video vignette. 三吻合器吻合术在直肠癌低位前切除术中的应用:可行性、安全性和肿瘤学最佳。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-05 DOI: 10.1111/codi.17249
Francesco Di Fabio, Niccolo Allievi, Brendan Moran
{"title":"Triple-stapling anastomosis in minimal access low anterior resection for rectal cancer: Feasible, safe and oncologically optimal-A video vignette.","authors":"Francesco Di Fabio, Niccolo Allievi, Brendan Moran","doi":"10.1111/codi.17249","DOIUrl":"https://doi.org/10.1111/codi.17249","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic-assisted extralevator abdominoperineal excision (ELAPE), posterior vaginectomy and perineal turnover flap for residual anal squamous cell carcinoma-A video vignette. 腹腔镜辅助腹外展式会阴切除术(ELAPE)、后阴道切除术及会阴翻转皮瓣治疗残留肛门鳞状细胞癌的影像分析。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-02 DOI: 10.1111/codi.17253
Nasra N Alam, Peter J Mitchell, Madhu Chaudhary, Milind Dalal, Srinivasan Iyer, Edward Parkin
{"title":"Laparoscopic-assisted extralevator abdominoperineal excision (ELAPE), posterior vaginectomy and perineal turnover flap for residual anal squamous cell carcinoma-A video vignette.","authors":"Nasra N Alam, Peter J Mitchell, Madhu Chaudhary, Milind Dalal, Srinivasan Iyer, Edward Parkin","doi":"10.1111/codi.17253","DOIUrl":"https://doi.org/10.1111/codi.17253","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A nationwide snapshot study on outcomes one year after surgery for chronic pilonidal sinus disease. 一项全国范围内对慢性毛窦疾病手术后一年结果的快照研究。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-02 DOI: 10.1111/codi.17217
Eleonora A Huurman, Christel A L de Raaff, Rosaline van den Berg, Sara J Baart, Bas P L Wijnhoven, Ruben Schouten, Edgar J B Furnée, Robert M Smeenk, Boudewijn R Toorenvliet

Aim: Managing pilonidal sinus disease (PSD) remains challenging due to high recurrence rates and morbidity associated with treatment. The aim of this study was to evaluate the outcomes one year after surgical treatment for chronic PSD in the Netherlands.

Method: Patients with PSD who underwent surgical treatment between March 1, 2020, and March 1, 2021, at 36 participating hospitals were included in a prospective observational cohort study. For the present study, only patients with chronic PSD were included for analysis. One-year after surgical treatment for PSD, all patients received questionnaires on wound healing, quality of life (QoL), and patient reported experience measures (PREMs). Primary outcome was recurrence rate. Secondary outcomes included QoL and PREMs.

Results: Of 681 included patients, 405 patients presented with chronic PSD and underwent surgical treatment. One-year questionnaires were completed by 289 out of 405 patients (71.4%). Patients underwent either excision with secondary wound healing (ESW, n = 73), excision with midline closure (EMC, n = 21), off-midline closure (OMC, n = 17), or a minimally invasive technique (MIT, n = 178). Patient-reported recurrence rates after ESW, EMC, OMC and MIT were 21.5%, 25%, 6.7% and 30.6%, respectively. Pain/discomfort and anxiety/depression were the most frequently reported problems affecting QoL. Patients that underwent OMC were satisfied the most with the care provided.

Conclusion: This study demonstrates variation in recurrence rates among surgical procedures for PSD. The highest rates were observed in the MIT and EMC group, while the OMC group exhibited the lowest rate. QoL outcomes differed among the surgical techniques. Patient satisfaction appears highest in the OMC group.

目的:由于高复发率和与治疗相关的发病率,治疗毛鞘窦疾病(PSD)仍然具有挑战性。本研究的目的是评估荷兰慢性PSD手术治疗一年后的结果。方法:将2020年3月1日至2021年3月1日期间在36家参与医院接受手术治疗的PSD患者纳入前瞻性观察队列研究。在本研究中,仅纳入慢性PSD患者进行分析。手术治疗PSD一年后,所有患者接受伤口愈合、生活质量(QoL)和患者报告体验量表(PREMs)的问卷调查。主要观察指标为复发率。次要结局包括QoL和PREMs。结果:在681例纳入的患者中,405例患者表现为慢性PSD并接受了手术治疗。405例患者中有289例(71.4%)完成了为期一年的问卷调查。患者接受了继发性伤口愈合切除(ESW, n = 73)、中线闭合切除(EMC, n = 21)、非中线闭合切除(OMC, n = 17)或微创技术(MIT, n = 178)。ESW、EMC、OMC和MIT术后复发率分别为21.5%、25%、6.7%和30.6%。疼痛/不适和焦虑/抑郁是影响生活质量的最常见问题。接受OMC的患者对所提供的护理最满意。结论:本研究表明不同手术方式治疗PSD的复发率存在差异。以MIT组和EMC组发生率最高,而OMC组发生率最低。生活质量结果因手术技术而异。患者满意度在OMC组中最高。
{"title":"A nationwide snapshot study on outcomes one year after surgery for chronic pilonidal sinus disease.","authors":"Eleonora A Huurman, Christel A L de Raaff, Rosaline van den Berg, Sara J Baart, Bas P L Wijnhoven, Ruben Schouten, Edgar J B Furnée, Robert M Smeenk, Boudewijn R Toorenvliet","doi":"10.1111/codi.17217","DOIUrl":"https://doi.org/10.1111/codi.17217","url":null,"abstract":"<p><strong>Aim: </strong>Managing pilonidal sinus disease (PSD) remains challenging due to high recurrence rates and morbidity associated with treatment. The aim of this study was to evaluate the outcomes one year after surgical treatment for chronic PSD in the Netherlands.</p><p><strong>Method: </strong>Patients with PSD who underwent surgical treatment between March 1, 2020, and March 1, 2021, at 36 participating hospitals were included in a prospective observational cohort study. For the present study, only patients with chronic PSD were included for analysis. One-year after surgical treatment for PSD, all patients received questionnaires on wound healing, quality of life (QoL), and patient reported experience measures (PREMs). Primary outcome was recurrence rate. Secondary outcomes included QoL and PREMs.</p><p><strong>Results: </strong>Of 681 included patients, 405 patients presented with chronic PSD and underwent surgical treatment. One-year questionnaires were completed by 289 out of 405 patients (71.4%). Patients underwent either excision with secondary wound healing (ESW, n = 73), excision with midline closure (EMC, n = 21), off-midline closure (OMC, n = 17), or a minimally invasive technique (MIT, n = 178). Patient-reported recurrence rates after ESW, EMC, OMC and MIT were 21.5%, 25%, 6.7% and 30.6%, respectively. Pain/discomfort and anxiety/depression were the most frequently reported problems affecting QoL. Patients that underwent OMC were satisfied the most with the care provided.</p><p><strong>Conclusion: </strong>This study demonstrates variation in recurrence rates among surgical procedures for PSD. The highest rates were observed in the MIT and EMC group, while the OMC group exhibited the lowest rate. QoL outcomes differed among the surgical techniques. Patient satisfaction appears highest in the OMC group.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic anterior resection: Transvaginal NICE approach-A video vignette. 机器人前切除术:经阴道NICE入路——视频片段。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-29 DOI: 10.1111/codi.17248
Nishtha Midha, Syed Althaf, Ravi Arjunan, Srinivas Chunduri, Pavan Sugoor
{"title":"Robotic anterior resection: Transvaginal NICE approach-A video vignette.","authors":"Nishtha Midha, Syed Althaf, Ravi Arjunan, Srinivas Chunduri, Pavan Sugoor","doi":"10.1111/codi.17248","DOIUrl":"https://doi.org/10.1111/codi.17248","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142754810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors associated with worse outcomes following chemoradiation therapy in patients with anal carcinoma. 肛门癌患者化疗后预后较差的相关因素。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-27 DOI: 10.1111/codi.17225
Muhammad Khurrum, Alejandro Cruz, David Schaub, Joseph Gunderson, Andrea Moreno, Daniom Tecle, Amanda Gong, Manijeh Assar, McKenzie Hargis, Danielle Alexandra Dooley, Jose Cruz, Valentine Nfonsam

Aim: Chemoradiation therapy (CRT) is considered as the first line of treatment for patients with squamous cell carcinoma of the anal canal. Following initial CRT, patients who present with either persistent or locally recurrent disease are treated by surgical intervention. The aim of our study is to determine the prognostic factors associated with failure of CRT and overall mortality in patients with anal squamous cell carcinoma (SCC).

Methods: We performed a 14-year analysis (2004-2017) of the National Cancer Database and included patients diagnosed with non-metastatic SCC of the anal canal who underwent CRT. Baseline patient characteristics including demographics, comorbidities and tumour characteristics were analysed. Outcome measures were needed for operative intervention after 4 months of initiation of CRT (failure of CRT) and 5-year overall mortality. Multivariate logistic regression analysis identified prognostic factors independently associated with failure of CRT.

Results: We included a total of 37 615 patients with anal SCC who received CRT. Predictors of operative intervention included male sex, higher Deyo-Charlson Comorbidity Index (DCCI) and higher primary tumour stage. The 5-year overall survival rate was 77.6%, and 2.4% of patients failed CRT, defined as requiring and undergoing surgical intervention within 4 months post-initiation of CRT. Median follow-up time was 47 (95% CI 24-84) months. Independent predictors of overall mortality within the first 5 years of diagnosis were increased age, male sex, Black race, non-insured status, higher DCCI, higher primary tumour grade, and higher primary tumour and lymph node stage. The 5-year survival rate was significantly lower in patients who underwent operative intervention compared to those who received CRT alone (57.4% vs. 78.1%; P < 0.01).

Conclusion: Our study showed that male sex, younger age, DCCI of 1 and 3, and increased tumour size were predictive of CRT failure among patients with anal SCC. Increased age, male sex, Black race, non-insured status, increased DCCI, and more aggressive tumour characteristics were associated with increased 5-year overall mortality. More importantly, patients who failed CRT had worse 5-year overall survival. Our findings support increased emphasis on intensive surveillance for these high-risk patient cohorts.

目的:化学放疗(CRT)被认为是肛管鳞状细胞癌患者的一线治疗方法。在最初的 CRT 治疗后,如果患者病情持续或局部复发,则需要进行手术治疗。我们的研究旨在确定与肛管鳞状细胞癌(SCC)患者 CRT 治疗失败和总死亡率相关的预后因素:我们对国家癌症数据库进行了为期 14 年(2004-2017 年)的分析,纳入了确诊为肛管非转移性 SCC 并接受 CRT 治疗的患者。分析了患者的基线特征,包括人口统计学、合并症和肿瘤特征。结果指标为开始 CRT 4 个月后需要手术干预(CRT 失败)和 5 年总死亡率。多变量逻辑回归分析确定了与CRT失败独立相关的预后因素:我们共纳入了37 615名接受CRT治疗的肛门SCC患者。手术干预的预测因素包括男性、较高的戴约-卡尔森综合指数(DCCI)和较高的原发肿瘤分期。5年总生存率为77.6%,2.4%的患者CRT治疗失败,即在开始CRT治疗后4个月内需要并接受手术干预。中位随访时间为 47 个月(95% CI 24-84 个月)。年龄增大、男性、黑人、无保险、DCCI较高、原发性肿瘤分级较高以及原发性肿瘤和淋巴结分期较高是确诊后前5年内总死亡率的独立预测因素。与单纯接受 CRT 的患者相比,接受手术干预的患者的 5 年生存率明显较低(57.4% 对 78.1%;P 结论:我们的研究表明,男性、年轻女性、原发性肿瘤分级和淋巴结分期较高的患者的 5 年生存率明显低于单纯接受 CRT 的患者:我们的研究表明,在肛门 SCC 患者中,男性、年轻、DCCI 为 1 和 3 以及肿瘤体积增大是 CRT 失败的预兆。年龄增大、男性、黑人、无保险、DCCI 增高以及肿瘤侵袭性更强与 5 年总死亡率增高有关。更重要的是,CRT失败的患者5年总生存率更低。我们的研究结果支持加强对这些高危患者群体的强化监测。
{"title":"Prognostic factors associated with worse outcomes following chemoradiation therapy in patients with anal carcinoma.","authors":"Muhammad Khurrum, Alejandro Cruz, David Schaub, Joseph Gunderson, Andrea Moreno, Daniom Tecle, Amanda Gong, Manijeh Assar, McKenzie Hargis, Danielle Alexandra Dooley, Jose Cruz, Valentine Nfonsam","doi":"10.1111/codi.17225","DOIUrl":"https://doi.org/10.1111/codi.17225","url":null,"abstract":"<p><strong>Aim: </strong>Chemoradiation therapy (CRT) is considered as the first line of treatment for patients with squamous cell carcinoma of the anal canal. Following initial CRT, patients who present with either persistent or locally recurrent disease are treated by surgical intervention. The aim of our study is to determine the prognostic factors associated with failure of CRT and overall mortality in patients with anal squamous cell carcinoma (SCC).</p><p><strong>Methods: </strong>We performed a 14-year analysis (2004-2017) of the National Cancer Database and included patients diagnosed with non-metastatic SCC of the anal canal who underwent CRT. Baseline patient characteristics including demographics, comorbidities and tumour characteristics were analysed. Outcome measures were needed for operative intervention after 4 months of initiation of CRT (failure of CRT) and 5-year overall mortality. Multivariate logistic regression analysis identified prognostic factors independently associated with failure of CRT.</p><p><strong>Results: </strong>We included a total of 37 615 patients with anal SCC who received CRT. Predictors of operative intervention included male sex, higher Deyo-Charlson Comorbidity Index (DCCI) and higher primary tumour stage. The 5-year overall survival rate was 77.6%, and 2.4% of patients failed CRT, defined as requiring and undergoing surgical intervention within 4 months post-initiation of CRT. Median follow-up time was 47 (95% CI 24-84) months. Independent predictors of overall mortality within the first 5 years of diagnosis were increased age, male sex, Black race, non-insured status, higher DCCI, higher primary tumour grade, and higher primary tumour and lymph node stage. The 5-year survival rate was significantly lower in patients who underwent operative intervention compared to those who received CRT alone (57.4% vs. 78.1%; P < 0.01).</p><p><strong>Conclusion: </strong>Our study showed that male sex, younger age, DCCI of 1 and 3, and increased tumour size were predictive of CRT failure among patients with anal SCC. Increased age, male sex, Black race, non-insured status, increased DCCI, and more aggressive tumour characteristics were associated with increased 5-year overall mortality. More importantly, patients who failed CRT had worse 5-year overall survival. Our findings support increased emphasis on intensive surveillance for these high-risk patient cohorts.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delorme's style rectal advancement flap and FiLaC and for a high anterior transsphincteric fistula: A video vignette. Delorme 式直肠前移皮瓣和 FiLaC 以及治疗高位经前括约肌瘘:视频短片。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-24 DOI: 10.1111/codi.17245
Easan Anand, Theo Pelly, Shivani Joshi, Kapil Sahnan, Stephen Preston, Phil Tozer
{"title":"Delorme's style rectal advancement flap and FiLaC and for a high anterior transsphincteric fistula: A video vignette.","authors":"Easan Anand, Theo Pelly, Shivani Joshi, Kapil Sahnan, Stephen Preston, Phil Tozer","doi":"10.1111/codi.17245","DOIUrl":"https://doi.org/10.1111/codi.17245","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A UK wide survey of general surgeons' experience of the primary repair of obstetric anal sphincter injuries. 英国普外科医生产科肛门括约肌损伤初级修复经验调查。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-20 DOI: 10.1111/codi.17244
Nada Elsaid, Gregory P Thomas, Emma V Carrington, Ruwan J Fernando, Carolynne J Vaizey

Aim: Obstetric anal sphincter injuries (OASIs) are associated with devastating consequences, mainly faecal incontinence. A timely and correct repair is necessary to reduce the risk of maternal morbidity. The aim was to explore the experience and practice of on-call general surgeons in the acute repair of OASIs.

Method: A cross-sectional, observational questionnaire study was performed. Registrars and consultants participating in an emergency general surgical rota in the UK were included. A 33-item questionnaire was disseminated over a 9-month period from April 2023. A descriptive, thematic analysis of the data was undertaken.

Results: In all, 310 responses were analysed. 42.3% of colorectal respondents (of which 29% were pelvic floor specialists), 24.3% of general surgeons, 16.7% of hepato-biliary surgeons and 13.7% of upper gastrointestinal surgeons were contacted to assist with an acute repair. Of those contacted, 52.3% typically assisted with a 3C or 4 tear, 54.2% received no training and 95.5% performed less than three acute repairs in the previous year. 57.6% of all respondents were not confident at all in the repair of these injuries, 55% highlighted a lack of experience and 36% mentioned a curricular gap.

Conclusion: Surgeons may be called to assist with an acute OASI repair, particularly in cases of severe anatomical disruption. This occurs infrequently. There is a lack of consensus as to who is responsible for these injuries. Obstetricians have structured training in both the recognition and repair of these injuries. This paper serves to highlight the lack of training for surgeons who report doing this surgery despite lacking the required competences.

目的:产科肛门括约肌损伤(OASI)会造成严重后果,主要是大便失禁。及时、正确的修复对于降低孕产妇发病风险十分必要。本研究旨在探讨值班普外科医生在急性肛门括约肌损伤修复方面的经验和做法:方法:进行了一项横断面观察问卷调查。研究对象包括参与英国急诊普通外科轮值的注册医师和顾问医师。从 2023 年 4 月起,在 9 个月的时间内发放了 33 个项目的调查问卷。对数据进行了描述性专题分析:共分析了 310 份回复。42.3%的结直肠受访者(其中 29% 为盆底专科医生)、24.3% 的普通外科医生、16.7% 的肝胆外科医生和 13.7% 的上消化道外科医生曾联系过协助进行急性修复。在这些受访者中,52.3% 的人通常会协助处理 3C 或 4 级撕裂,54.2% 的人未接受过任何培训,95.5% 的人在过去一年中进行过少于三次急性修复。在所有受访者中,57.6%的人对此类损伤的修复完全没有信心,55%的人强调缺乏经验,36%的人提到了课程差距:结论:外科医生可能需要协助进行急性 OASI 修复,尤其是在解剖结构严重破坏的情况下。这种情况并不常见。对于由谁对这些损伤负责还缺乏共识。产科医生在识别和修复这些损伤方面接受过系统培训。本文旨在强调外科医生缺乏培训的问题,尽管他们缺乏所需的能力,但仍有报告称他们做了这种手术。
{"title":"A UK wide survey of general surgeons' experience of the primary repair of obstetric anal sphincter injuries.","authors":"Nada Elsaid, Gregory P Thomas, Emma V Carrington, Ruwan J Fernando, Carolynne J Vaizey","doi":"10.1111/codi.17244","DOIUrl":"10.1111/codi.17244","url":null,"abstract":"<p><strong>Aim: </strong>Obstetric anal sphincter injuries (OASIs) are associated with devastating consequences, mainly faecal incontinence. A timely and correct repair is necessary to reduce the risk of maternal morbidity. The aim was to explore the experience and practice of on-call general surgeons in the acute repair of OASIs.</p><p><strong>Method: </strong>A cross-sectional, observational questionnaire study was performed. Registrars and consultants participating in an emergency general surgical rota in the UK were included. A 33-item questionnaire was disseminated over a 9-month period from April 2023. A descriptive, thematic analysis of the data was undertaken.</p><p><strong>Results: </strong>In all, 310 responses were analysed. 42.3% of colorectal respondents (of which 29% were pelvic floor specialists), 24.3% of general surgeons, 16.7% of hepato-biliary surgeons and 13.7% of upper gastrointestinal surgeons were contacted to assist with an acute repair. Of those contacted, 52.3% typically assisted with a 3C or 4 tear, 54.2% received no training and 95.5% performed less than three acute repairs in the previous year. 57.6% of all respondents were not confident at all in the repair of these injuries, 55% highlighted a lack of experience and 36% mentioned a curricular gap.</p><p><strong>Conclusion: </strong>Surgeons may be called to assist with an acute OASI repair, particularly in cases of severe anatomical disruption. This occurs infrequently. There is a lack of consensus as to who is responsible for these injuries. Obstetricians have structured training in both the recognition and repair of these injuries. This paper serves to highlight the lack of training for surgeons who report doing this surgery despite lacking the required competences.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor's Choice November 2024 编辑推荐 2024 年 11 月。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-18 DOI: 10.1111/codi.17223
Dieter Hahnloser
{"title":"Editor's Choice November 2024","authors":"Dieter Hahnloser","doi":"10.1111/codi.17223","DOIUrl":"10.1111/codi.17223","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"26 11","pages":"1868"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The creation of an AI taskforce for colorectal surgery in the United Kingdom and Ireland 在英国和爱尔兰成立结直肠外科人工智能工作组。
IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-18 DOI: 10.1111/codi.17235
James Kinross, Justin Davies
{"title":"The creation of an AI taskforce for colorectal surgery in the United Kingdom and Ireland","authors":"James Kinross,&nbsp;Justin Davies","doi":"10.1111/codi.17235","DOIUrl":"10.1111/codi.17235","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"26 11","pages":"1869-1870"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1